Dr méd. Volker Kirchner

FMH Internal Medecine and Oncology-Hematology-MHEM


Languages

French, English and German

Work experience

Memeber of the Board Swiss Medical Network
COO Chief Operating Officer, Genolier Cancer Centre
Programme Director / Haematology-Oncology, Medical Affairs, Transfusion Medicine, Genolier
Secretary Genolier Medical Commission
President Medical Society of the region
President elected 2018-2019 Swiss Society of Medical Oncology
Co-President, Swiss Society of Medical Oncology
Board member of the Swiss Cancer Network
Scientific board member of FoROMe
since 1998 Practice, internal medicine, oncology, haematology, Clinique de Genolier, Switzerland
Supervising physician, haematology-oncology, transfusion medicine, Swissmedic haemovigilance/pharmacovigilance/materiovigilance, Genolier, Switzerland
Clinical Affiliate, Memorial Sloan Kettering International Oncology Program, NY, USA
Oncology/haematology, Maunoir, Eaux-Vives, Geneva, Switzerland
Oncology/haematology, Chantpoulet medical group, Eaux-Vives, Geneva, Switzerland
2001–2003 Associate, Oncocare, Sonnenhof AG, Bern: www.oncocare.ch, Chief physician of Laboratoire, Sonnenhof AG, Bern, Switzerland
Supervising physician, haemovigilance programme, Sonnenhof AG, Bern
Supervising physician, hospital hygiene, Sonnenhof AG, Bern
1997–1998 Fellow, Oncology-Haematology, Department of Medicine, Memorial Sloan-Kettering Center, New-York, NY USA
1997 Clinic Director, Clinique de Médecine 2, Prof F. Waldvogel, MD, HCUG
1993–1996 Research Fellow, Harvard Medical School, Cell Biology Department and Beth Israel Hospital, Division of Signal Transduction, Boston, MA, USA: Prof L.C. Cantley, PhD
1992–1993 Five-month basic research rotation, Foundation for Medical Research, Prof W. Schelgel, PhD, HCUG
1991–1993 Deputy Clinic Director, Clinique de Médecine 2, Prof F. Waldvogel, MD, HCUG
1990–1991 Assistant physician, haematology, Medical Polyclinic, Prof P.A. Miescher, Prof H. Stalder, HCUG
1989–1990 Assistant physician, oncology, onco-haematology department, Prof P. Alberto, HCUG
1986–1989 Assistant physician, Clinique de Médecine 2, Prof F. Waldvogel, Cantonal University Hospital, Geneva (HCUG), Switzerland
1986 Physician, vaccination campaign, Médecins sans Frontières (Doctors Without Borders)

Education

since 2005 FMH-certified oncology, ongoing training
since 2001 FMH-certified internal medicine, ongoing training
2005 Postgraduate in Pharmaceutical (HEC Lausanne)
2003 Postgraduate diploma in Health Economics and Management (MHEM) IEMS, HEC; Lausanne, Switzerland
2003 Postgraduate certificate in palliative care (CHUV Lausanne)
1998 FMH-certified oncology, under the former FMH Switzerland term: oncology/haematology
1997 Doctorate in medicine, Geneva
1997 FMH, Internal medicine, Switzerland
1997 Certified member, European Society of Medical Oncology (ESMO)
1991 ECFMG certification
1986 University Geneva, University Hospital Geneva-Switzerland
IEMS-HEC University Lausanne (MHEM)
Harvard Boston USA
Memorial-Sloan Kettering Cancer Center NY USA

Memberships

Clinical Affiliate Memorial-Sloan Kettering International Cancer Program
FMH, SVM, AMG, GROG, GHORIV, SSMO, SSH, SST, SSIM, ASCO, ASTRO, ASH, ESMO, EHA

Remedial and supportive treatment of oncological and haematological disorders as part of an integrative, interdisciplinary approach.

Traitement de l’anémie en gynécologie: utilisation de l’époétine en onco-gynécologie et en chirurgie gynécologique. V. Kirchner et Anaemia Working Group. Revue médicale Suisse, 15; 14.04.2005

Kirchner, V. Die fortschrittliche Anämiebehandlung in der Gynäkologie. Gynäkologie. 2003; 3: 24-27

Kirchner V. Ré-adaptation en oncologie médicale. Médecine et Hygiène 2000; 58:1186-92

Kirchner V, Aapro MS, Terrey JP, Alberto P. The cost effectiveness of granisetron compared to metoclopramide with dexamethasone. (Thesis, Geneva Medical School, Medecine et Hygiene, 1997)

Kirchner V, Aapro MS, Terrey J-P, Alberto P. Granisetron compared with granisetron plus dexamethasone. A double-blind cross-over study (European Journal of Cancer. 33(10):1605-10, 1997)

Kirchner V, Aapro MS. Evaluating the Cost-Effectiveness of New Drugs: the "Setrons" as an Example. European School of Oncology Monographs, 1996

Aapro MS, Kirchner V, Terrey JP. Is anticipatory nausea and vomiting a thing of the past.  Br J Cancer 1994 May;69(5):957-60

Joss R.A., Bacchi M., Buser K., Kirchner V., et al.(In behalf of the Swiss Groupe for Clinical Cancer Research, SAKK). Antiemetic efficacy of ondansetron plus dexamethasone is superior to ondansetron alone in naive and in patients refractory to other agents. Ann Oncol 1994 Mar;5(3):253-8

Kirchner V, Aapro MS, Alberto P, O'Grady P., Busch B, Boyce M. Phase I trial of MDL 73.147 EF: a new 5-HT3 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Ann Oncol 1993 Jun;4(6):481-4

Kirchner V. Pragmatic approaches to measuring costs. Anticancer Drugs 1993 Dec;4 Suppl 3:13-20

Beris Ph, Darbellay R, Jeannet M, Kirchner V, Miescher PA. A new case of the initiation codon mutation (ATG-ACG) in a Swiss family is the result of a recent spontaneous mutation.  Am J Hematol 1993 Mar;42(3):248-53

Kirchner V., Aapro MS, Terrey J-P., (pour le groupe Suisse d'étude sur le Granisetron). Efficacité antiémétique du Granisetron: une expérience en Suisse. Médecine et Hygiène 1993; 51:1510-1514

Aapro M, Achille E, Bolle J-F, Graber P, Keim D, Kirchner V, Kurtz J, Marin J-L, Rohner S. L'association MIVIP-radiothérapie bifractionnée dans les cancers infiltrants de la vessie.  Bulletin de la Société Francaise de Cancérologie privée, 1993; 25-34

25.07.2017
Recertification du Genolier Swiss Oncology Network par le Swiss Cancer Network
Le Genolier Swiss Oncology Network a obtenu sa certification annuelle pour la deuxième année consécutive auprès du Swiss Cancer Network.

14.07.2016
La Clinique de Genolier est fière de vous annoncer la nomination du Docteur Aapro au sein du Comité Scientifique de l’ABC4
Les Docteurs Edya Fuhrmann, Claudine Helg, Volker Kirchner et Matti Aapro sont les Oncologues et Hématologues spécialistes qui exercent à la Clinique de Genolier.

12.04.2016
Cancer, pas de demi-mesure
Le Dr Volker Kirchner, oncologue réputé de la Clinique de Genolier, met en avant les bénéfices d’une médecine multidisciplinaire pour améliorer le confort et le quotidien des patients.